Phenotype, function and chimaerism of monocyte-derived blood dendritic cells after allogeneic haematopoietic stem cell transplantation
- 26 September 2003
- journal article
- website
- Published by Wiley in British Journal of Haematology
- Vol. 123 (1) , 119-126
- https://doi.org/10.1046/j.1365-2141.2003.04588.x
Abstract
Summary. Dendritic cells (DCs) are essential for initiating T‐cell responses against either host‐ or leukaemia‐specific antigens. We analysed phenotype, allostimulatory capacity and chimaerism of monocyte‐derived DCs (moDCs) serially in 28 patients receiving allogeneic stem cell grafts after conventional myeloablative (n = 14) or reduced‐intensity conditioning (RIC, n = 14). Although the recovery of phenotype and function of moDCs after myeloablative stem cell transplantation (SCT) was prompt, there was a trend to a lower expression of co‐stimulatory molecules and major histocompatibility antigen class II antigens on mature moDCs in patients who had received RIC transplants. Similarly, the allostimulatory capacity of mature moDCs after RIC transplants was reduced for up to 6 months. Six out of 14 (43%) RIC transplant patients showed a pattern of mixed chimaerism within the first 3 months after transplant. RIC transplant patients with a mixed donor DC chimaerism had a significantly higher risk of relapse (75% versus 35% for patients with full donor DC chimaerism, P = 0·03) but a lower incidence of acute graft‐versus‐host disease (25% versus 56% for patients with full donor DC chimaerism, P = 0·157). These data, although preliminary, provide evidence that DC function is impaired after RIC transplants and that DC chimaerism may have an impact on graft‐versus‐host and graft‐versus‐leukaemia reactions.Keywords
This publication has 30 references indexed in Scilit:
- Persistence of host dendritic cells after transplantation is associated with graft-versus-host diseaseTransplantation and Cellular Therapy, 2003
- Origin and subset distribution of peripheral blood dendritic cells in patients with chronic graft-versus-host disease1Transplantation, 2003
- Characterization of human blood dendritic cell subsetsBlood, 2002
- Mixed Chimerism and Transplantation ToleranceAnnual Review of Medicine, 2001
- Melphalan and purine analog–containing preparative regimens: reduced-intensity conditioning for patients with hematologic malignancies undergoing allogeneic progenitor cell transplantationBlood, 2001
- T CELL MIXED CHIMERISM IS SIGNIFICANTLY CORRELATED TO A DECREASED RISK OF ACUTE GRAFT-VERSUS-HOST DISEASE AFTER ALLOGENEIC STEM CELL TRANSPLANTATION 1Transplantation, 2001
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Detection of engraftment and mixed chimerism following bone marrow transplantation using PCR amplification of a highly variable region-variable number of tandem repeats (VNTR) in the von Willebrand factor geneAnnals of Hematology, 1991
- CLINICAL MANIFESTATIONS OF GRAFT-VERSUS-HOST DISEASE IN HUMAN RECIPIENTS OF MARROW FROM HL-A-MATCHED SIBLING DONOR,STransplantation, 1974
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958